Vanda Pharmaceuticals Inc Cash Flow Reinvestment Rate
Vanda Pharmaceuticals Inc cash flow reinvestment rate. Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Reinvestment Rate of 2.41x as of March 2024, reinvesting $18.23 Million (capex $7.00K plus investments $-18.22 Million) from operating cash flow of $7.57 Million. Explore VNDA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Vanda Pharmaceuticals Inc (2009–2023)
Cash flow reinvestment rate of Vanda Pharmaceuticals Inc from 2009 to 2023. Historical reinvestment intensity for Vanda Pharmaceuticals Inc across 8 annual periods. Explore capital reinvestment ratio of Vanda Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Vanda Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2009–2023)
Vanda Pharmaceuticals Inc cash flow reinvestment rate by year from 2009 to 2023. Year-by-year capital reinvestment analysis for Vanda Pharmaceuticals Inc. For the full cash flow conversion analysis, see VNDA operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 8.40x | $107.54 Million | $12.80 Million | $383.00K | ▲ +423.9% |
| 2022 | 1.60x | $51.28 Million | $31.98 Million | $679.00K | ▲ +34.2% |
| 2021 | 1.19x | $76.70 Million | $64.21 Million | $552.00K | ▲ +49.0% |
| 2020 | 0.80x | $41.50 Million | $51.77 Million | $1.79 Million | ▼ -46.1% |
| 2019 | 1.49x | $68.31 Million | $45.95 Million | $1.02 Million | ▼ -59.3% |
| 2018 | 3.66x | $109.66 Million | $29.99 Million | $25.37 Million | ▲ +71.2% |
| 2015 | 2.14x | $26.60 Million | $12.45 Million | $2.53 Million | ▲ +2915.0% |
| 2009 | 0.07x | $12.00 Million | $169.34 Million | $12.00 Million | — |